272 related articles for article (PubMed ID: 16868480)
1. On the mechanisms of 12-O-tetradecanoylphorbol-13-acetate-induced growth arrest in pancreatic cancer cells.
Salabat MR; Ding XZ; Flesche JB; Ujiki MB; Robin TP; Talamonti MS; Bell RH; Adrian TE
Pancreas; 2006 Aug; 33(2):148-55. PubMed ID: 16868480
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of p21(WAF1/CIP1) leads to morphologic changes and esterase activity in TPA-mediated differentiation of human prostate cancer cell line TSU-Pr1.
Sugibayashi R; Shimizu T; Suzuki T; Yamamoto N; Hamada H; Takeda K
Oncogene; 2001 Mar; 20(10):1220-8. PubMed ID: 11313866
[TBL] [Abstract][Full Text] [Related]
3. 12-O-Tetradecanoyl phorbol-13-acetate (TPA)-induced growth arrest is increased by silibinin by the down-regulation of cyclin B1 and cdc2 and the up-regulation of p21 expression in MDA-MB231 human breast cancer cells.
Kim S; Lee HS; Lee SK; Kim SH; Hur SM; Kim JS; Kim JH; Choe JH; Shin I; Yang JH; Lee JE; Nam SJ
Phytomedicine; 2010 Dec; 17(14):1127-32. PubMed ID: 20554189
[TBL] [Abstract][Full Text] [Related]
4. TIS21/BTG2/PC3 is expressed through PKC-delta pathway and inhibits binding of cyclin B1-Cdc2 and its activity, independent of p53 expression.
Ryu MS; Lee MS; Hong JW; Hahn TR; Moon E; Lim IK
Exp Cell Res; 2004 Sep; 299(1):159-70. PubMed ID: 15302583
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
Arita Y; Buffolino P; Coppock DL
Exp Cell Res; 1998 Aug; 242(2):381-90. PubMed ID: 9683525
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
Wen-Sheng W
Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
[TBL] [Abstract][Full Text] [Related]
7. TPA-induced p21 expression augments G2/M arrest through a p53-independent mechanism in human breast cancer cells.
Han J; Kim S; Yang JH; Nam SJ; Lee JE
Oncol Rep; 2012 Feb; 27(2):517-22. PubMed ID: 22020547
[TBL] [Abstract][Full Text] [Related]
8. Involvement of both extracellular signal-regulated kinase and c-jun N-terminal kinase pathways in the 12-O-tetradecanoylphorbol-13-acetate-induced upregulation of p21(Cip1) in colon cancer cells.
Lin SY; Liang YC; Ho YS; Tsai SH; Pan S; Lee WS
Mol Carcinog; 2002 Sep; 35(1):21-8. PubMed ID: 12203364
[TBL] [Abstract][Full Text] [Related]
9. Involvement of p21 in the PKC-induced regulation of the G2/M cell cycle transition.
Barboule N; Lafon C; Chadebech P; Vidal S; Valette A
FEBS Lett; 1999 Feb; 444(1):32-7. PubMed ID: 10037143
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
11. Activation of extracellular signal-regulated kinase (ERK) in G2 phase delays mitotic entry through p21CIP1.
Dangi S; Chen FM; Shapiro P
Cell Prolif; 2006 Aug; 39(4):261-79. PubMed ID: 16872362
[TBL] [Abstract][Full Text] [Related]
12. PKC pathway and ERK/MAPK pathway are required for induction of cyclin D1 and p21Waf1 during 12-o-tetradecanoylphorbol 13-acetate-induced differentiation of myeloleukemia cells.
Matsumoto E; Hatanaka M; Bohgaki M; Maeda S
Kobe J Med Sci; 2006; 52(6):181-94. PubMed ID: 17329956
[TBL] [Abstract][Full Text] [Related]
13. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
Okumura K; Shirasawa S; Nishioka M; Sasazuki T
Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
[TBL] [Abstract][Full Text] [Related]
14. Oxidant species are involved in T/B-mediated ERK1/2 phosphorylation that activates p53-p21 axis to promote KSHV lytic cycle in PEL cells.
Gonnella R; Yadav S; Gilardini Montani MS; Granato M; Santarelli R; Garufi A; D'Orazi G; Faggioni A; Cirone M
Free Radic Biol Med; 2017 Nov; 112():327-335. PubMed ID: 28801242
[TBL] [Abstract][Full Text] [Related]
15. Regulation of plasminogen activators in human thyroid follicular cells and their relationship to differentiated function.
Susarla R; Watkinson JC; Eggo MC
J Cell Physiol; 2007 Sep; 212(3):643-54. PubMed ID: 17458906
[TBL] [Abstract][Full Text] [Related]
16. Modulation of cyclin D1 and its signaling components by the phorbol ester TPA and the tyrosine phosphatase inhibitor vanadate.
Yan S; Wenner CE
J Cell Physiol; 2001 Mar; 186(3):338-49. PubMed ID: 11169972
[TBL] [Abstract][Full Text] [Related]
17. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a.
Wen-Sheng W
Oncogene; 2003 Feb; 22(7):955-63. PubMed ID: 12592382
[TBL] [Abstract][Full Text] [Related]
18. Requirement for Ras/Raf/ERK pathway in naringin-induced G1-cell-cycle arrest via p21WAF1 expression.
Kim DI; Lee SJ; Lee SB; Park K; Kim WJ; Moon SK
Carcinogenesis; 2008 Sep; 29(9):1701-9. PubMed ID: 18296682
[TBL] [Abstract][Full Text] [Related]
19. Phorbol ester-induced low density lipoprotein receptor gene expression in HepG2 cells involves protein kinase C-mediated p42/44 MAP kinase activation.
Kumar A; Chambers TC; Cloud-Heflin BA; Mehta KD
J Lipid Res; 1997 Nov; 38(11):2240-8. PubMed ID: 9392422
[TBL] [Abstract][Full Text] [Related]
20. Role of ROS and MAPK in TPA-induced ICAM-1 expression in the myeloid ML-1 cell line.
Traore K; Sharma RB; Burek CL; Trush MA
J Cell Biochem; 2007 Mar; 100(4):1010-21. PubMed ID: 17131377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
